NSC |
Compound |
Enrichment |
Correlation |
NSC 617937 |
Null |
0.0235591674342969 |
0.20746024 |
NSC 619311 |
Null |
0.0235591674342969 |
-0.058472256 |
NSC 726195 |
2-phenyl 3-[(6-ethyl, 4-amino, 5-(4-chlorophenyl) pyrimidin-2-yl)] quinazolin-4-one |
0.0235591674342969 |
0.065705715 |
NSC 744622 |
4,8,13,17,21-Pentamethyl-docosa-4,8,12,16,20-pentaenoic acid[1-(3,3-difluoro-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-2-oxo-1,2-dihydro-pyrimidin-4-yl]-amide |
0.0235591674342969 |
0.235844 |
NSC 81206 |
Null |
0.0235591674342976 |
0.32887792 |
NSC 122060 |
Ethanesulfonic acid, compd. with N-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy]propyl]carbamoyl]metanilyl fluoride (1:1) (8CI) (MF2) |
0.0282295482823984 |
0.11550302 |
NSC 123111 |
Mitomycin derivative T 53 |
0.0282295482823984 |
0.29592219 |
NSC 135925 |
Null |
0.0282295482823984 |
0.24148442 |
NSC 145669 |
4(1H)-Quinazolinone, 2,3-dihydro-2-(1-naphthalenyl)- (9CI) |
0.0282295482823984 |
-0.1321529 |
NSC 15372 |
4-Hydroxyphenyl-.beta.-naphthylamine |
0.0282295482823984 |
0.039990479 |